Valuation
- Market cap
- 995,000
- Revenue TTM
- $0
- Net income TTM
- $-19,390,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- -1.11
Trading
- Volume
- 301,400
- Avg volume
- 2,416,665
- Day's range
- $1.15 – $1.34
- Shares out
- 706,000
- Stochastic %K
- 3%
- Beta
- 0.73
- Analysts
- Strong Buy
- Price target
- —
Company profile
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed it...
Show more
GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 201 842 7715
- Website
- https://glucotrack.com
- Address
- 301 Route 17 North, Suite 800, Rutherford, United States
Latest news
No headlines yet.
